Search

Search Constraints

You searched for: Author/Creator Kim, Richard D.

Search Results

2. A phase I/Ib study of regorafenib and nivolumab in mismatch repair proficient advanced refractory colorectal cancer. (July 2022)

3. Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical Trials. (February 2018)

5. Determining Optimal Follow-up for Patients With Anal Cancer Following Chemoradiation. (May 2020)

9. Metagenomics and chemotherapy‐induced nausea: A roadmap for future research. Issue 3 (13th October 2021)

10. Multicenter, randomized, double‐blind phase 2 trial of FOLFIRI with regorafenib or placebo as second‐line therapy for metastatic colorectal cancer. Issue 15 (15th June 2018)